Ann Arbor, Michigan Patent of the Year – 2024/2025
Optofluidic Bioassay LLC has been awarded the 2024/2025 Patent of the Year for innovation in rapid diagnostic technology. Their invention, detailed in U.S. Patent No. 11860108, titled ‘Optofluidic diagnostics system’, introduces a compact and integrated system for fast, precise, point-of-care testing.
This breakthrough device merges fluidic control and optical sensing into a single platform. It enables accurate detection of biological markers using small sample volumes and delivers results in real time. The system is designed for use in settings where speed and mobility are critical, including clinics, emergency care, and remote locations.
Unlike traditional diagnostics that require bulky machines or lab environments, this system uses a disposable cartridge with embedded channels to guide fluid samples. Optical sensors monitor these samples as they interact with embedded reagents, producing instant, readable outputs without human interpretation.
Its modular design allows adaptation for various tests, from infectious diseases to environmental monitoring. With minimal training, healthcare providers can deploy it for reliable, rapid assessments that save time and support faster decision-making.
Optofluidic Bioassay LLC’s innovation brings high-performance diagnostics closer to patients. It opens new possibilities for early detection, improved access to care, and streamlined workflows in both urban and rural healthcare systems.